Program Introduction and Patient Education

The discussion begins by emphasizing the importance of comprehensive patient education at treatment initiation. CDK4/6 inhibitors require strict adherence, laboratory monitoring, and awareness of adverse effects—making patient understanding critical for success. Panelists highlight the pharmacist’s central role in counseling, establishing trust, and ensuring patients are well-informed about dosing, potential adverse events, and early intervention strategies.

Effective patient education, they note, is not limited to a single counseling session but should involve ongoing communication and reinforcement. Visual aids, written instructions, and digital reminders are cited as useful tools for helping patients navigate complex regimens. The discussion also addresses how patients’ anxiety, comorbidities, or socioeconomic barriers may affect comprehension and adherence, requiring tailored counseling techniques.

Overall, the introduction underscores that empowering patients through clear education fosters shared decision-making, strengthens therapeutic partnerships, and ultimately leads to better clinical outcomes and treatment persistence.